-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Atorvastatin lactone is a widely used drug for the treatment of high cholesterol levels, which can cause heart disease.
It is a synthetic drug that is derived from a natural substance called monacolin K, which is found in red yeast rice.
The production process of atorvastatin lactone involves several chemical reactions and steps, which are carried out in a laboratory or industrial setting.
The first step in the production of atorvastatin lactone is the synthesis of an intermediate compound called mevalonate, which is a key building block for many biological molecules.
Mevalonate is synthesized through several chemical reactions, including the condensation of acetyl-CoA and pyruvate, followed by the addition of carbon dioxide and the removal of water.
The next step in the production of atorvastatin lactone is the synthesis of an intermediate compound called HMG-CoA reductase, which is an enzyme that catalyzes the conversion of HMG-CoA to mevalonate.
HMG-CoA reductase is synthesized by expression of a gene that encodes the enzyme in a host cell, such as bacteria or yeast.
The synthesis of HMG-CoA reductase involves several steps, including the transcription of the gene into mRNA, the translation of mRNA into protein, and the folding of the protein into its active form.
Once the HMG-CoA reductase enzyme has been synthesized, it is used to catalyze the conversion of HMG-CoA to mevalonate, which is then converted to other intermediate compounds through a series of chemical reactions.
These intermediate compounds are then transformed into atorvastatin lactone through a process called nitrogen mustard alkylation, which involves the reaction of atorvastatin with a compound called 2-chloro-1,3-bis(2-nitrophenyl)propane (DBNPP).
The nitrogen mustard alkylation reaction is carried out in several steps, including the formation of acyl nitrogen mustards, the hydrolysis of the acyl nitrogen mustards to form the corresponding alkyl halides, and the conversion of the alkyl halides to the final product, atorvastatin lactone.
The specific conditions used in the nitrogen mustard alkylation reaction, such as the concentration of reactants and solvents, the temperature and time of the reaction, and the presence of catalysts or other reagents, can vary depending on the specific conditions of the reaction.
Once the atorvastatin lactone has been synthesized, it is purified through several steps, including filtration, crystallization, and chromatography.
The purified atorvastatin lactone is then formulated into a dosage form, such as a tablet or capsule, which can be taken orally by a patient.
In summary, the production process of atorvastatin lactone involves several chemical reactions and steps, which are carried out in a laboratory or industrial setting.
The process involves the synthesis of an intermediate compound called mevalonate, which is used to catalyze the conversion of HMG-CoA to other intermediate compounds, followed by the synthesis of atorvastatin lactone through a process called nitrogen mustard alkylation.
The final product is then purified and formulated into a dosage form for use by patients.